Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Tackling Cost: A Prescription for Spending Wisely.

Tempero M.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):633. doi: 10.6004/jnccn.2019.0030. No abstract available.

PMID:
31200360
2.

Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.

Hennessy D, Sanmartin C, Ronksley P, Weaver R, Campbell D, Manns B, Tonelli M, Hemmelgarn B.

Health Rep. 2016 Jun 15;27(6):3-8.

3.

Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program.

Aroke H, Buchanan A, Wen X, Ragosta P, Koziol J, Kogut S.

J Manag Care Spec Pharm. 2018 Mar;24(3):214-224. doi: 10.18553/jmcp.2018.24.3.214.

4.

Prescription drug spending: contribution to health care spending and cost containment strategies.

Rivers PA, Hall NG, Frimpong J.

J Health Care Finance. 2006 Spring;32(3):8-19.

PMID:
18975728
5.

Getting from choosing wisely to spending wisely.

Hoverman JR.

J Oncol Pract. 2014 May;10(3):223-5. doi: 10.1200/JOP.2013.001305. Epub 2014 Feb 25. No abstract available.

PMID:
24569920
6.

Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P.

J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

7.

Choosing Wisely campaigns globally: A shared approach to tackling the problem of overuse in healthcare.

Born KB, Levinson W.

J Gen Fam Med. 2018 Dec 21;20(1):9-12. doi: 10.1002/jgf2.225. eCollection 2019 Jan.

8.
9.
10.

Sources of regional variation in Medicare Part D drug spending.

Donohue JM, Morden NE, Gellad WF, Bynum JP, Zhou W, Hanlon JT, Skinner J.

N Engl J Med. 2012 Feb 9;366(6):530-8. doi: 10.1056/NEJMsa1104816.

11.

Gaining Coverage Through Medicaid Or Private Insurance Increased Prescription Use And Lowered Out-Of-Pocket Spending.

Mulcahy AW, Eibner C, Finegold K.

Health Aff (Millwood). 2016 Sep 1;35(9):1725-33. doi: 10.1377/hlthaff.2016.0091. Epub 2016 Aug 17.

PMID:
27534776
12.

Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries.

Gaskin DJ, Briesacher BA, Limcangco R, Brigantti BL.

Am J Geriatr Pharmacother. 2006 Jun;4(2):96-111.

PMID:
16860257
13.

Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?

Mahmoudi E, Jensen GA.

Health Serv Res. 2014 Apr;49(2):502-25. doi: 10.1111/1475-6773.12099. Epub 2013 Sep 18.

14.

Role of pharmacy services in accountable care organizations.

Colla CH, Lewis VA, Beaulieu-Jones BR, Morden NE.

J Manag Care Spec Pharm. 2015 Apr;21(4):338-44.

15.

Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.

Hwang TJ, Jain N, Lauffenburger JC, Vokinger KN, Kesselheim AS.

JAMA Intern Med. 2019 Jan 14. doi: 10.1001/jamainternmed.2018.6417. [Epub ahead of print]

PMID:
30640379
16.

High-Cost Users of Prescription Drugs: A Population-Based Analysis from British Columbia, Canada.

Weymann D, Smolina K, Gladstone EJ, Morgan SG.

Health Serv Res. 2017 Apr;52(2):697-719. doi: 10.1111/1475-6773.12492. Epub 2016 Apr 18.

17.

Medical Marketing in the United States, 1997-2016.

Schwartz LM, Woloshin S.

JAMA. 2019 Jan 1;321(1):80-96. doi: 10.1001/jama.2018.19320.

PMID:
30620375
18.

Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries.

Stuart B, Lloyd J, Zhao L, Kamal-Bahl S.

Curr Med Res Opin. 2008 Aug;24(8):2377-87. doi: 10.1185/03007990802262275. Epub 2008 Jul 9.

PMID:
18616864
19.

Choosing Wisely: a neurosurgical perspective on neuroimaging for headaches.

Hawasli AH, Chicoine MR, Dacey RG Jr.

Neurosurgery. 2015 Jan;76(1):1-5; quiz 6. doi: 10.1227/NEU.0000000000000560.

Supplemental Content

Support Center